BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 30934860)

  • 1. Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis.
    Zhang J; Zhou Y; Tang PMK; Cheng ASL; Yu J; To KF; Kang W
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging role of Hippo pathway in gastric and other gastrointestinal cancers.
    Kang W; Cheng AS; Yu J; To KF
    World J Gastroenterol; 2016 Jan; 22(3):1279-88. PubMed ID: 26811664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of
    Goto H; Nishio M; To Y; Oishi T; Miyachi Y; Maehama T; Nishina H; Akiyama H; Mak TW; Makii Y; Saito T; Yasoda A; Tsumaki N; Suzuki A
    Development; 2018 Mar; 145(6):. PubMed ID: 29511023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting YAP1/TAZ in nonsmall-cell lung carcinoma: From molecular mechanisms to precision medicine.
    Mui CW; Chan WN; Chen B; Cheung AH; Yu J; Lo KW; Ke H; Kang W; To KF
    Int J Cancer; 2023 Feb; 152(4):558-571. PubMed ID: 35983734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The transcription factor RUNX2 fuels YAP1 signaling and gastric cancer tumorigenesis.
    Guo Z; Zhou K; Wang Q; Huang Y; Ji J; Peng Y; Zhang X; Zheng T; Zhang Z; Chong D; Yang Z
    Cancer Sci; 2021 Sep; 112(9):3533-3544. PubMed ID: 34160112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Verteporfin targeting YAP1/TAZ-TEAD transcriptional activity inhibits the tumorigenic properties of gastric cancer stem cells.
    Giraud J; Molina-Castro S; Seeneevassen L; Sifré E; Izotte J; Tiffon C; Staedel C; Boeuf H; Fernandez S; Barthelemy P; Megraud F; Lehours P; Dubus P; Varon C
    Int J Cancer; 2020 Apr; 146(8):2255-2267. PubMed ID: 31489619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mammalian Hippo pathway: regulation and function of YAP1 and TAZ.
    Kodaka M; Hata Y
    Cell Mol Life Sci; 2015 Jan; 72(2):285-306. PubMed ID: 25266986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hippo Pathway as Drug Targets in Cancer Therapy and Regenerative Medicine.
    Nagashima S; Bao Y; Hata Y
    Curr Drug Targets; 2017; 18(4):447-454. PubMed ID: 26758663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helicobacter pylori-induced YAP1 nuclear translocation promotes gastric carcinogenesis by enhancing IL-1β expression.
    Wu Y; Shen L; Liang X; Li S; Ma L; Zheng L; Li T; Yu H; Chan H; Chen C; Yu J; Jia J
    Cancer Med; 2019 Jul; 8(8):3965-3980. PubMed ID: 31145543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt, RSPO and Hippo Signalling in the Intestine and Intestinal Stem Cells.
    Kriz V; Korinek V
    Genes (Basel); 2018 Jan; 9(1):. PubMed ID: 29316729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PPARδ Interacts with the Hippo Coactivator YAP1 to Promote SOX9 Expression and Gastric Cancer Progression.
    Song S; Wang Z; Li Y; Ma L; Jin J; Scott AW; Xu Y; Estrella JS; Song Y; Liu B; Johnson RL; Ajani JA
    Mol Cancer Res; 2020 Mar; 18(3):390-402. PubMed ID: 31796534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transduction of mechanical and cytoskeletal cues by YAP and TAZ.
    Halder G; Dupont S; Piccolo S
    Nat Rev Mol Cell Biol; 2012 Sep; 13(9):591-600. PubMed ID: 22895435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agrin as a Mechanotransduction Signal Regulating YAP through the Hippo Pathway.
    Chakraborty S; Njah K; Pobbati AV; Lim YB; Raju A; Lakshmanan M; Tergaonkar V; Lim CT; Hong W
    Cell Rep; 2017 Mar; 18(10):2464-2479. PubMed ID: 28273460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of the Hippo Effectors YAP1/TAZ in Tumors of Soft Tissue and Bone.
    Isfort I; Elges S; Cyra M; Berthold R; Renner M; Mechtersheimer G; Åman P; Larsson O; Ratner N; Hafner S; Simmet T; Schliemann C; Rossig C; Dirksen U; Grünewald I; Wardelmann E; Huss S; Hartmann W; Trautmann M
    Sci Rep; 2019 Dec; 9(1):19704. PubMed ID: 31873172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Computational Model of YAP/TAZ Mechanosensing.
    Sun M; Spill F; Zaman MH
    Biophys J; 2016 Jun; 110(11):2540-2550. PubMed ID: 27276271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging role of lncRNAs as mechanical signaling molecules in mechanotransduction and their association with Hippo-YAP signaling: a review.
    Lin S; He X; Wang Y; Chen Y; Lin A
    J Zhejiang Univ Sci B; 2024 Apr; 25(4):280-292. PubMed ID: 38584091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Up-regulated acylglycerol kinase (AGK) expression associates with gastric cancer progression through the formation of a novel YAP1-AGK-positive loop.
    Huang S; Cao Y; Guo H; Yao Y; Li L; Chen J; Li J; Xiang X; Deng J; Xiong J
    J Cell Mol Med; 2020 Oct; 24(19):11133-11145. PubMed ID: 32827244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STUB1 suppresseses tumorigenesis and chemoresistance through antagonizing YAP1 signaling.
    Tang DE; Dai Y; Lin LW; Xu Y; Liu DZ; Hong XP; Jiang HW; Xu SH
    Cancer Sci; 2019 Oct; 110(10):3145-3156. PubMed ID: 31393050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alantolactone is a natural product that potently inhibits YAP1/TAZ through promotion of reactive oxygen species accumulation.
    Nakatani K; Maehama T; Nishio M; Otani J; Yamaguchi K; Fukumoto M; Hikasa H; Hagiwara S; Nishina H; Mak TW; Honma T; Kondoh Y; Osada H; Yoshida M; Suzuki A
    Cancer Sci; 2021 Oct; 112(10):4303-4316. PubMed ID: 34289205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Mechanism of Hippo-YAP1/TAZ Pathway in Heart Development, Disease, and Regeneration.
    Chen X; Li Y; Luo J; Hou N
    Front Physiol; 2020; 11():389. PubMed ID: 32390875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.